MPM ASSET MANAGEMENT LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 39 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MPM ASSET MANAGEMENT LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$2,662,000
-37.6%
2,464,8070.0%1.10%
-69.6%
Q4 2018$4,264,000
-70.2%
2,464,8070.0%3.61%
-62.7%
Q3 2018$14,296,000
+35.5%
2,464,8070.0%9.68%
+136.9%
Q2 2018$10,549,000
-27.1%
2,464,8070.0%4.09%
-26.7%
Q1 2018$14,468,000
+49.0%
2,464,807
+17.3%
5.57%
+43.2%
Q4 2017$9,707,000
+48.3%
2,101,171
+76.3%
3.89%
+21.8%
Q3 2017$6,545,000
-4.7%
1,192,0800.0%3.19%
+7.1%
Q2 2017$6,866,000
-0.2%
1,192,0800.0%2.98%
-9.8%
Q1 2017$6,878,000
+9.5%
1,192,0800.0%3.31%
+11.6%
Q4 2016$6,282,000
+163.5%
1,192,0800.0%2.96%
+279.6%
Q3 2016$2,384,000
-2.9%
1,192,0800.0%0.78%
-2.0%
Q2 2016$2,456,000
-3.7%
1,192,0800.0%0.80%
+0.8%
Q1 2016$2,551,000
-25.7%
1,192,0800.0%0.79%
+29.0%
Q4 2015$3,433,000
-35.3%
1,192,0800.0%0.61%
-24.9%
Q3 2015$5,305,000
-13.6%
1,192,0800.0%0.82%
-20.5%
Q2 2015$6,139,000
-27.7%
1,192,0800.0%1.03%
-43.3%
Q1 2015$8,488,000
+1.7%
1,192,0800.0%1.81%
-2.3%
Q4 2014$8,345,000
+14.4%
1,192,0800.0%1.85%
-22.4%
Q3 2014$7,296,000
-32.8%
1,192,0800.0%2.39%
-34.6%
Q2 2014$10,860,000
+11.9%
1,192,0800.0%3.65%
-11.1%
Q1 2014$9,704,000
+26.2%
1,192,0800.0%4.11%
+65.4%
Q4 2013$7,689,000
-35.8%
1,192,0800.0%2.48%
-26.5%
Q3 2013$11,980,0001,192,0803.38%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,192,080$9,704,0004.11%
Ghost Tree Capital, LLC 219,977$1,790,0001.06%
JBF Capital, Inc. 148,178$1,205,0000.18%
Polar Capital LLP 900,604$7,326,0000.17%
SPHERA FUNDS MANAGEMENT LTD. 80,000$651,0000.15%
HAMILTON LANE ADVISORS LLC 33,141$270,0000.11%
Jasper Ridge Partners, L.P. 63,996$521,0000.03%
Weiss Multi-Strategy Advisers LLC 95,000$773,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 550,000$4,474,0000.01%
AXA S.A. 292,625$2,381,0000.01%
View complete list of CONATUS PHARMACEUTICALS INC shareholders